Pennant Group Inc (PNTG)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Pennant Group Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 40.30 $ — 92% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 26.0% passed
- More than 10% revenue growth is expected for the coming year 7.8% failed
- Share count grows by less than 3% a year 5.4% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 39.1% failed
- Gross margin at 40% or higher and without meaningful erosion 12.9% failed
- Goodwill from acquisitions does not grow faster than revenue 24.5% failed
- Net debt below twice EBITDA 7.2 x EBITDA failed
- Operating cash flow covers the profits of the last three years 55 m passed
- Return on capital at 15% or higher, or up versus two years ago 6.3% passed
- Insiders hold at least 10% or are net buyers 5.0% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 11.7% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.35 | 1.33 – 1.38 | 1,165 | 14.8% | 7 |
| 12/31/2027 | 1.60 | 1.50 – 1.78 | 1,256 | 18.0% | 7 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.28 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.16 | 13.30 | 189 | 29.40 | 3.00 | 21 | 17 |
| 2025: Q1 | 0.22 | 36.90 | 210 | 33.70 | 3.70 | -21 | -23 |
| 2025: Q2 | 0.20 | 8.40 | 220 | 30.10 | 3.20 | 35 | 32 |
| 2025: Q3 | 0.17 | -12.90 | 229 | 26.80 | 2.70 | 14 | 11 |
| 2025: Q4 | 0.24 | 49.50 | 289 | 53.20 | 3.00 | 21 | 14 |
| 2026: Q1 | 0.24 | 7.90 | 285 | 36.00 | 3.00 | -3 | -9 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 217 | 13 | 8 | 0.28 | 16 | – | – |
| 2017 | 251 | 15 | 10 | 0.35 | 17 | 55 | 88 |
| 2018 | 286 | 21 | 16 | 0.56 | 23 | 56 | 98 |
| 2019 | 339 | 6 | 3 | 0.09 | 10 | 71 | 448 |
| 2020 | 391 | 19 | 16 | 0.52 | 50 | 97 | 507 |
| 2021 | 440 | 5 | 3 | 0.09 | -18 | 110 | 530 |
| 2022 | 473 | 13 | 7 | 0.22 | 9 | 121 | 512 |
| 2023 | 545 | 25 | 13 | 0.44 | 33 | 140 | 540 |
| 2024 | 695 | 38 | 23 | 0.71 | 39 | 293 | 680 |
| 2025 | 948 | 51 | 30 | 0.84 | 48 | 333 | 968 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
The Pennant Group, Inc. bietet Gesundheitsdienstleistungen in den USA an.
| Employees | 9,700 |
|---|---|
| Headquarters | Eagle, ID |
| Address | 1675 East Riverside Drive, 83616 Eagle, United States |
| Phone | 208 401 1400 |
| Website | pennantgroup.com |
| IPO Date | 1. Oct 2019 |
| ISIN | US70805E1091 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Brent J. Guerisoli | CEO & Chairman | 1981 |
| John J. Gochnour | President & COO | 1984 |
| Lynette B. Walbom CPA | Chief Financial Officer | 1978 |
| Kirk S. Cheney J.D. | Executive VP, General Counsel & Corporate Secretary | 1982 |
| Jason P. Steik | Chief Clinical Officer | 1984 |
| Andrew Rider | President of Pinnacle Senior Living LLC | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Morris Gregory K Sr. | Director | Other | 1,900 | 0.00 | – |
| 15. Jul 2026 | Snapper Suzanne D. | Director | Other | 1,900 | 0.00 | – |
| 15. Jul 2026 | Nackel John G. | Director | Other | 1,900 | 0.00 | – |
| 15. Jul 2026 | Christensen Christopher R. | Director | Other | 1,900 | 0.00 | – |
| 15. Jul 2026 | Lamb Scott E | Director | Other | 2,400 | 0.00 | – |
| 15. Jul 2026 | Smith Barry M | Director | Other | 1,900 | 0.00 | – |
| 15. Jul 2026 | Covey Stephen M R | Director | Other | 1,900 | 0.00 | – |
| 10. Jul 2026 | Guerisoli Brent | Chief Executive Officer | Sell | 3,159 | 41.57 | 131,304 |
| 10. Jul 2026 | Guerisoli Brent | Chief Executive Officer | Other | 6,248 | 4.54 | 28,366 |
| 7. Jul 2026 | Guerisoli Brent | Chief Executive Officer | Sell | 3,165 | 40.51 | 128,214 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.